Active ingredient
Vedolizumab
3 finished FDA listings contain Vedolizumab as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- VEDOLIZUMAB
- Dosage forms
- Injection, Powder, Lyophilized, For Solution, Injection, Solution
- Routes
- Intravenous, Subcutaneous
- Manufacturers / labelers
- 1
- Strengths listed
- 108 mg/.68ml · 300 mg/5ml
- Brand names in FDA listings
- Entyvio, Entyvio Pen
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1538097
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| BLA 125476 | TAKEDA PHARMS USA | 2014-05-20 | 1 |
| BLA 761133 | TAKEDA PHARMS USA | 2023-09-27 | 2 |
Official labeling on DailyMed
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.